Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Internet

Is there a Way To Overcome the Shortcomings of Bitcoin

Bitcoins have been regularly termed as a potent alternative currency. However, Bitcoin enthusiasts would not be particularly pleased with the apparent lack of regulation coupled with the price volatility. The recent news of bitcoin corruption and robbery does not make for a good image either. Plus, the price volatility of Bitcoins in 2015 does not help in attracting a lot of currency usage. Here in … Continue reading Is there a Way To Overcome the Shortcomings of Bitcoin

Richard Atkins
Finance, Internet

Google (NASDAQ GOOG) News: Looking at the Top 3 Exciting Upcoming Google Innovations

The search engine giants Google (NASDAQ GOOG) remain one of the most intriguing and innovative companies in the market today. In this article we will take a look at the top 3 innovative projects which have been taken up by Google, all of which are sure to catch your attention. Google along with the likes of Apple, has been a top innovator, always looking up … Continue reading Google (NASDAQ GOOG) News: Looking at the Top 3 Exciting Upcoming Google Innovations

Richard Atkins
Finance, Internet

Stock in News: Google (NASDAQ GOOG) Makes High With New CFO

The search engine giants, Google (NASDAQ GOOG), has been performing remarkably well for the past couple of days. This recent peak came after the announcement of Ruth Popat as the new company CFO. As it turns out, the market took the announcement really well. The stock ended up rising to a two week high, with analysts remaining bullish on the stock. Ruth Popat succeeds Patrick … Continue reading Stock in News: Google (NASDAQ GOOG) Makes High With New CFO

Richard Atkins
Finance, Internet

Stock in News: Expectations High on Microsoft (NASDAQ MSFT) Stock

Microsoft (NASDAQ MSFT) has been making news lately. With the much hyped Windows 10 on the verge of a launch, it seems like the stock would be in for a positive show in the coming months. Hopes are definitely high for the stock. The analysts also seem to be positively interested in the stock. In this article, we will take a closer look at what … Continue reading Stock in News: Expectations High on Microsoft (NASDAQ MSFT) Stock

Richard Atkins
Finance, Mobile

The Competition in Smartphone Operating System Segment for Microsoft (NASDAQ MSFT)

The smartphone operating system market is currently dominated by two major giants namely, Google and Apple. Therefore it is not surprising that the name of Microsoft does not come up in any such discussions. Microsoft’s Windows Phone commands less than 10% of the OS market which is remarkably lower as compared to Android and iOS. But Microsoft have recently started turning things around. Under new … Continue reading The Competition in Smartphone Operating System Segment for Microsoft (NASDAQ MSFT)

Richard Atkins
Finance

Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of this writing of $1.65. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance … Continue reading Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Richard Atkins